Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Contract Win

10 Apr 2006 07:00

Embargoed Release: 07:00hrs Monday 10th April 2006 Sopheon Plc (`Sopheon') Campina Chooses Sopheon System to Enhance Global Innovation Processes European Dairy Foods Leader Persuaded by Accolade's Superior Functionality and StrongCustomer Endorsements Sopheon, the international software and services company, announced today thatCampina, one of Europe's leading dairy companies and a prominent player in theglobal dairy industry, has selected Sopheon's Accolade product innovationprocess and portfolio management system to support the enhancement of itsinnovation processes. The enterprise-wide deployment will provide access tousers in 20 countries in Europe, Asia and North America.Campina's aim is to achieve international growth by offering innovative dairyproducts in Europe and Asia while maintaining leading market positionsworld-wide for specific dairy ingredients. It faces a challenge common totoday's food companies: satisfying consumer demand for a constant flow of new,appetizing and high-quality products at the lowest price. Campina'sresearch-and-development efforts are concentrated in three centers located inThe Netherlands. Consumer products for the German and Dutch markets aredeveloped by the Campina Innovation international development center atWageningen. The company produces desserts, yogurt, cheese, butter and a varietyof other consumer and industrial products under brand names such as Campina,Landliebe, Yogho Yogho and Mona, a leading line of dairy treats.One of the central elements of Campina's growth strategy is a sustained focuson innovation. The company recently developed a plan for introducing enhanced,uniform innovation processes and capabilities that would displace a mix oflegacy product-development systems being used by its various operating groups.The initiative included finding a technology solution that could reduce theadministrative workload associated with product-development process executionwhile helping to lower product-development project costs, acceleratetime-to-market and increase success rates for new products.The technology selection process centered on a detailed review of ten productlifecycle management solutions. Campina's choice of Sopheon's Accolade systemwas based primarily on the software's superior ease-of-use, its out-of-the-boxsupport for stage gate process methodology, and the speed with which it couldbe implemented. Another important Accolade advantage was its ability tointegrate with information tools already in use throughout the company, such asMicrosoft and SAP technologies and Campina's own timesheet system. Campina'sdecision was also impacted by the strength of endorsements from companies thathad implemented the Sopheon solution."Innovation is a strategic pillar of Campina's business success," said MichaelErdl, director of research and development for consumer products at Campina."We can't afford to risk the critical processes that underpin our innovationefforts on an unproven or functionally limited support system. One of thethings that really separated Sopheon from other suppliers was the enthusiastic,compelling testimonials we heard from Accolade users. We spoke with top foodcompanies who told us about the important contributions Accolade had made toadvancing their processes and productivity. The experiences these users sharedconvinced us that Accolade was a high-value solution that could play a majorrole in helping Campina reach its innovation goals.""Strong, differentiating features and functionality have been the cornerstoneof Accolade's broad market acceptance," said Nigel Cordery, European directorfor Sopheon. "But customer references are our most powerful competitiveadvantage. The willingness of Accolade users to tell prospects about themeasurable benefits of implementing our software is a principal reason thenumber of Accolade clients grew by 30% in 2005. Best of all, the solution'sconsistent performance assures new adopters that they will achieve the samekind of positive results. We're delighted to have Campina, one of the leadinginnovators in its industry, join the ranks of Accolade users."Sopheon Accolade‚® is a registered trademark of Sopheon plc.Campina, Landliebe, Yogho Yogho and Mona are registered trademarks of Campina.All other trademarks and registered trademarks are the soleproperty of their respective owners.About CampinaCampina is an international co-operative company active in the development,production, sale and distribution of dairy and dairy-related consumer productsand advanced ingredients for the food and pharmaceutical industries. Campinahas an annual turnover of around ¢â€š¬3.6 billion and some 6,800 employees. Thecompany holds leading positions in the markets in which it operates. For moreinformation, please visit www.campina.com.About SopheonSopheon (LSE: SPE) is an international provider of software and services thathelp organizations improve the business impact of product innovation. TheSopheon Accolade‚® product innovation process and portfolio management systemautomates gate- or phase-based product development processes and providesstrategic decision support that allows companies to increase revenue andprofits from new products. Sopheon is listed on the AIM Market of the LondonStock Exchange and on the Euronext in the Netherlands. For more information,please visit www.sopheon.com. # # # For further information contact:Arif Karimjee, CFO Sopheon plc Tel : + 44 (0) 1483 685 735 Andrew Tan Hansard Communications Tel : + 44 (0) 207 245 1100 + 44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010ENDSOPHEON PLC
Date   Source Headline
3rd Nov 202310:15 amRNSForm 8.5 (EPT/NON-RI)
3rd Nov 20238:54 amRNSForm 8.3 - Rivomore Limited - Sopheon plc
2nd Nov 20239:34 amRNSForm 8.5 (EPT/NON-RI)
1st Nov 20233:44 pmEQSForm 8.3 - Apex Fundrock Limited : Form 8.3 Apex Fundrock Limited Re: Sopheon PLC
1st Nov 20231:55 pmRNSForm 8.3 - Sopheon plc
1st Nov 202311:23 amRNSForm 8.5 (EPT/NON-RI)
1st Nov 202310:51 amGNWForm 8.3 - [Sopheon plc - Opening Declaration - 31 03 2023] - (CGAML)
1st Nov 202310:35 amRNSForm 8.3 - Sopheon PLC
31st Oct 20231:00 pmRNSStatement re Possible Offer
24th Aug 20237:00 amRNSInterim Results
10th Jul 20237:00 amRNSAcquisition
15th Jun 20235:06 pmRNSIssue of Equity
8th Jun 20231:35 pmRNSResult of AGM
8th Jun 20237:00 amRNSAGM Statement
13th Apr 20234:20 pmRNSIssue of Equity
31st Mar 20239:14 amRNSIssue of Equity
27th Mar 20234:23 pmRNSDirector Shareholdings
24th Mar 20237:00 amRNSDirector Share Purchases
23rd Mar 20237:00 amRNSFinal Results
22nd Feb 20234:59 pmRNSIssue of Equity
6th Feb 20237:00 amRNSDirectorate Change and Notice of Results
30th Jan 20237:00 amRNSTrading Update
20th Sep 202212:01 pmRNSSopheon launches Acclaim Line of SaaS Offerings
2nd Sep 202210:06 amRNSIssue of Equity
1st Sep 20227:00 amRNSNew Release of Award-winning Innovation Product
24th Aug 20227:00 amRNSInterim Results
16th Aug 20227:00 amRNSFive-year, $11.2m Enterprise Agreement
3rd Aug 202210:18 amRNSHolding(s) in Company
21st Jun 202212:20 pmRNSHolding(s) in Company
9th Jun 20222:30 pmRNSResult of AGM
9th Jun 20227:00 amRNSAGM Statement
6th Jun 20226:02 pmRNSIssue of Equity & TVR
23rd May 20227:00 amRNSDirector Dealing & Issue of Equity
18th May 20227:00 amRNSAcquisition
29th Apr 20225:12 pmRNSHolding(s) in Company
7th Apr 20227:00 amRNSNew Sopheon Software Release
1st Apr 202212:10 pmRNSDirector Shareholdings
24th Mar 20227:00 amRNSFinal Results
25th Jan 20227:00 amRNSTrading Update
17th Jan 20223:15 pmRNSIssue of Equity
20th Dec 20217:00 amRNSAcquisition and Trading Update
24th Sep 20211:52 pmRNSIssue of Equity
16th Sep 202110:00 amRNSHolding(s) in Company
13th Sep 20215:24 pmRNSIssue of Equity
31st Aug 20216:14 pmRNSDirector Shareholdings
25th Aug 20217:00 amRNSInterim Results
13th Jul 20217:00 amRNSNew Release Drives Business Transformation
23rd Jun 20217:00 amRNSSopheon Earns Authority to Operate for NAVSEA
15th Jun 20219:54 amRNSIssue of Equity
10th Jun 202111:43 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.